Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Therapeutic Plenary Session 1104

Management of Hyperkinetic Movement Disorders

Sunday, October 5, 2025
15:30 - 17:00 | Room TBD

In this session, the faculty will present current treatment approaches involving medications and invasive therapies for tremor, myoclonus and Huntington’s disease.


Chairs:

Francisco Cardoso, Brazil
Marina De Koning-Tijssen, Netherlands

Presenters:

Tremor
Peter Bain, United Kingdom

Myoclonus
Emmanuel Roze, France

Huntington's Disease
John O'Sullivan, Australia

CSPC Liaisons:

Francesca Morgante, United Kingdom

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Select appropriate medications and invasive therapies (MRgFUS, DBS) for isolated tremor syndromes
  2. Develop an evidence based treatment plan for the management of non-epileptic myoclonic syndromes
  3. Select an appropriate comprehensive management plan for Huntington’s disease, including pharmacological and non-pharmacological options

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

Focus

Clinical